Handa Pharma monthly revenue
Handa Pharma
| Period | Released | Revenue (NT$) | MoM % | YoY % | YTD Rev (NT$) |
|---|---|---|---|---|---|
| Jun 2026 | Jul 15, 2026 | NT$0.1B | +13.5% | -21.8% | NT$0.4B |
| May 2026 | Jun 17, 2026 | NT$0.1B | +14.8% | -24.4% | NT$0.3B |
| Apr 2026 | May 17, 2026 | NT$0.1B | -21.1% | -88.9% | NT$0.3B |
| Mar 2026 | Apr 17, 2026 | NT$0.1B | +43.2% | +11.0% | NT$0.2B |
| Feb 2026 | Mar 17, 2026 | NT$0.1B | -27.4% | +4.2% | NT$0.1B |
| Jan 2026 | — | NT$0.1B | — | +32.1% | NT$0.1B |
| Dec 2025 | — | NT$0.1B | — | +106.5% | NT$1.7B |
| Nov 2025 | — | NT$0.1B | — | +35.6% | NT$1.6B |
| Oct 2025 | — | NT$0.1B | — | +34.4% | NT$1.5B |
| Sep 2025 | — | NT$0.1B | — | +37.7% | NT$1.4B |
| Aug 2025 | — | NT$0.3B | — | +410.9% | NT$1.3B |
| Jul 2025 | — | NT$0.1B | — | -14.2% | NT$1B |
| Jun 2025 | — | NT$0.1B | — | +23.0% | NT$0.9B |
| May 2025 | — | NT$0.1B | — | +28.0% | NT$0.8B |
| Apr 2025 | — | NT$0.6B | — | +870.8% | NT$0.7B |
| Mar 2025 | — | NT$0.1B | — | +19.9% | NT$0.2B |
| Feb 2025 | — | NT$0.1B | — | -25.3% | NT$0.1B |
| Jan 2025 | — | NT$0.1B | — | -34.7% | NT$0.1B |
| Dec 2024 | — | NT$0.1B | — | -41.9% | NT$0.8B |
| Nov 2024 | — | NT$0.1B | — | -39.4% | NT$0.8B |
| Oct 2024 | — | NT$0.1B | — | -21.6% | NT$0.7B |
| Sep 2024 | — | NT$0.1B | — | +13.3% | NT$0.6B |
| Aug 2024 | — | NT$0.1B | — | -29.4% | NT$0.6B |
| Jul 2024 | — | NT$0.1B | — | -6.2% | NT$0.5B |
Values are shown in billions of TWD. Latest period: Jun 2026. Updated 2026-07-29. Source: Taiwan public company filings
Monthly Sales is available publicly. Financials, KPIs, reports, transcripts and the rest of Research require the Research tier.